Institutional investors purchased a net $1.6 million shares of SPNC during the quarter ended March 2013 and now own 71.29% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
| Individual stakeholders | 5.09% |
| Other institutional | 46.19% |
| Mutual fund holders | 25.11% |